摘要
目的通过检测血清中β2-微球蛋白,评价其在鉴别良恶性肿瘤中的应用价值。方法采用散射比浊法测定33例良性肿瘤患者与38例恶性肿瘤患者血清β2-微球蛋白的含量并与与41例健康对照组比较,对所测得的数据用配对t检验进行统计学处理,计算t值。结果恶性肿瘤患者组血清β2-微球蛋白含量显著高于良性肿瘤组与健康对照组(P<0.01),良性肿瘤组与健康对照组血清β2-微球蛋白含量差异无显著意义(P>0.05)。结论测定患者血清中的β2-微球蛋白对良恶性肿瘤的鉴别诊断有重要临床意义。
Objective Through the examination blood serum in β2-the microballoons protein,appraises it to distinguish in the good malignant tumor the application value. Methods Uses the scattering turbidimetric method to determine 33 cases benign tumor patient and with compares with 38 cases malignant tumor patient blood serum β2-microballoons protein content with 41 cases healthy control groups,to the data which obtains with pairs the T-test to carry on statistics processing,calculates the t value.Results Malignant tumor patient group blood serum β2-microballoons protein content obviously was higher than the benign tumor group and the healthy control group（P〈0.01）,the benign tumor group and the healthy control group blood serum β2-microballoons protein content difference was not remarkable（P〉0.05）. Conclusion Determines in the patient blood serum β2-the microballoons protein to have the vital clinical significance to the good malignant tumor differential diagnosis.
出处
《中国实用医药》
2010年第8期68-69,共2页
China Practical Medicine
关键词
Β2-微球蛋白
良恶性肿瘤
鉴别
β2-microballoons protein
Good malignant tumor
Distinction
